Literature DB >> 24255130

The relationship between markers of extracellular cardiac matrix turnover: infarct healing and left ventricular remodelling following primary PCI in patients with first-time STEMI.

Cord Manhenke1, Thor Ueland, Bodh I Jugdutt, Kristin Godang, Pål Aukrust, Kenneth Dickstein, Stein Ørn.   

Abstract

AIMS: We investigated the temporal changes in circulating levels of markers of extracellular cardiac matrix (ECCM) turnover and their relationship with infarct size (IS), ejection fraction (EF), and left ventricular (LV) volumes, determined by serial cardiac magnetic resonance (CMR) imaging in patients with first-time ST-elevation myocardial infarction (STEMI). METHODS AND
RESULTS: Forty-two patients with a first-time STEMI, successfully revascularized by primary percutaneous coronary intervention (pPCI) had serum samples taken prior to pPCI, 2, 7 days, 2 months, and 1 year following STEMI for the analysis of the markers of collagen synthesis, and collagen degradation. Late enhancement and cine CMR was performed on Days 2, 7, 2 months, and 1-year post-STEMI. There was a significant increase in type I collagen degradation following STEMI that was not accompanied by an increase in collagen type I synthesis until 2 months and 1 year. In contrast to the delay in type I collagen synthesis, there was an immediate increase in type III collagen synthesis that was sustained for 1 year. N-terminal procollagen type I levels assessed prior to pPCI were predictive of adverse LV remodelling at all CMR time-points.
CONCLUSIONS: Our findings indicate a net type I collagen breakdown in the first week following STEMI compensated by an early increase in collagen type III synthesis. There is an increase in both type I and III collagen synthesis markers at 2 months and 1 year, indicating a persistent increase in collagen turnover even in these apparently successfully treated patients.

Entities:  

Keywords:  Collagen turnover; Extracellular cardiac matrix; Remodelling; STEMI

Mesh:

Substances:

Year:  2013        PMID: 24255130     DOI: 10.1093/eurheartj/eht482

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

Review 1.  Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Authors:  Nikolaos G Frangogiannis; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

2.  Biological variation of extracellular matrix biomarkers in patients with stable chronic heart failure.

Authors:  Tobias Täger; Clara Wiebalck; Hanna Fröhlich; Anna Corletto; Hugo A Katus; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2017-08-04       Impact factor: 5.460

Review 3.  Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.

Authors:  Helena Kuivaniemi; Gerard Tromp
Journal:  Gene       Date:  2019-05-07       Impact factor: 3.688

4.  Cluster analysis of extracellular matrix biomarkers predicts the development of impaired systolic function within 1 year of acute myocardial infarction.

Authors:  Morgane M Brunton-O'Sullivan; Ana S Holley; Bijia Shi; Scott A Harding; Peter D Larsen
Journal:  Heart Vessels       Date:  2022-07-27       Impact factor: 1.814

5.  Serum neprilysin levels are associated with myocardial stunning after ST-elevation myocardial infarction.

Authors:  Damien Legallois; Clémence Macquaire; Amir Hodzic; Stéphane Allouche; Ismaïl El Khouakhi; Alain Manrique; Paul Milliez; Eric Saloux; Farzin Beygui
Journal:  BMC Cardiovasc Disord       Date:  2020-07-02       Impact factor: 2.298

6.  Echocardiographic diastolic function evolution in patients with an anterior Q-wave myocardial infarction: insights from the REVE-2 study.

Authors:  João Pedro Ferreira; Christophe Bauters; Romain Eschalier; Zohra Lamiral; Renaud Fay; Olivier Huttin; Nicolas Girerd; Faiez Zannad; Florence Pinet; Patrick Rossignol
Journal:  ESC Heart Fail       Date:  2018-11-20

7.  The relationship between Fibroblast Growth Factor 23 (FGF23) and cardiac MRI findings following primary PCI in patients with acute first time STEMI.

Authors:  Inga Strand Thorsen; Lasse G Gøransson; Thor Ueland; Pål Aukrust; Cord A Manhenke; Øyvind Skadberg; Grete Jonsson; Stein Ørn
Journal:  Int J Cardiol Heart Vasc       Date:  2021-02-19

Review 8.  Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction.

Authors:  Michał Węgiel; Tomasz Rakowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-03-27       Impact factor: 1.426

9.  Preventive Effect Observation of Dapagliflozin on Middle and Later Ventricular Remodeling in Patients with Acute ST Segment Elevation Anterior Wall Myocardial Infarction: A Single-Center, Retrospective Cohort Study.

Authors:  Zeyan Liu; Lijun Liu; Hao Zhang; Yang Jiang; Hengtong Wang
Journal:  J Healthc Eng       Date:  2022-04-15       Impact factor: 3.822

10.  A combined biomarker approach for characterising extracellular matrix profiles in acute myocardial infarction.

Authors:  Morgane M Brunton-O'Sullivan; Ana S Holley; Kathryn E Hally; Gisela A Kristono; Scott A Harding; Peter D Larsen
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.